RETRONIX SEMICONDUCTOR (UK) LIMITED

Company number SC753691 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

RETRONIX SEMICONDUCTOR (UK) LIMITED - Analysis Report

Company Number: SC753691

Analysis Date: 2025-07-20 11:03 UTC

Financial Health Assessment of RETRONIX SEMICONDUCTOR (UK) LIMITED


1. Financial Health Score: B

Explanation:
Retronix Semiconductor (UK) Limited demonstrates a generally sound financial position for a young company (incorporated Dec 2022) with positive net assets and working capital. The company maintains a modest but stable asset base and adequate liquidity ("healthy cash flow") as reflected by positive current assets exceeding current liabilities. However, the scale of net assets is relatively small, and no profit & loss detail was filed, limiting insight into profitability trends. Overall, the company shows early-stage financial stability but has room to develop stronger capital buffers and profitability indicators.


2. Key Vital Signs

Metric Value (£) Interpretation
Fixed Assets 6,980 Small tangible asset base, typical for a startup or service-based business.
Current Assets 276,162 Includes cash and debtors; good liquidity position.
Cash at Bank 111,865 Healthy cash reserves indicating good short-term solvency.
Debtors 164,297 Receivables are substantial; effective collections needed to maintain cash flow.
Current Liabilities 259,678 Payables and short-term debts; less than current assets ensuring positive working capital.
Net Current Assets 16,484 Positive working capital ("healthy blood flow") but relatively thin margin; watch liquidity tightly.
Net Assets (Shareholders Funds) 23,464 Positive equity base indicating the company is solvent with assets exceeding liabilities.
Average Employees 17 Moderate staffing level, implying operational complexity and associated overheads.

Additional Notes:

  • The company’s accounts are unaudited abridged, limiting the detail available for deep analysis.
  • No profit & loss account was filed, so profitability and cash generation trends are unknown.
  • The company is classified as a small entity, eligible for simplified reporting.
  • Control is tightly held by a single individual with 75-100% shareholding and voting rights, implying centralized decision-making.

3. Diagnosis

The company presents with the "vital signs" of a start-up or early-stage enterprise in a specialized technical sector (SIC 74909: Other professional, scientific and technical activities). The positive net current assets and net assets indicate solvency and a positive equity base, which are good indicators of financial health. The cash reserve is adequate relative to current liabilities, suggesting no immediate liquidity distress.

However, the relatively low net current assets compared to total current assets suggest a narrow margin of safety if liabilities rise or cash collections slow ("symptoms of financial tightness"). The absence of profit and loss data means we cannot assess operational profitability or cash flow generation from core activities, which is critical for long-term sustainability.

The company's balance sheet is lean with limited fixed assets and a moderate workforce, indicating a service or knowledge-based operation rather than capital-intensive manufacturing. The directors’ reports confirm compliance with small company exemptions, and no negative indicators such as overdue filings or insolvency status are noted.


4. Recommendations

To improve financial wellness and guard against risks, the company should consider:

  • Enhance Profitability Transparency: File full profit and loss accounts to provide stakeholders with insight into operational performance and profitability trends. This transparency aids in diagnosing "internal health" beyond balance sheet metrics.

  • Strengthen Working Capital Management: Monitor debtor collections carefully to maintain cash flow. Explore policies to reduce days sales outstanding (DSO) and negotiate favorable terms with suppliers to optimize liquidity.

  • Build Capital Reserves: Aim to increase retained earnings and net assets over time to create a financial buffer against unforeseen events or market downturns.

  • Regular Financial Reviews: Implement periodic financial health check-ups (quarterly reviews) to catch early symptoms of distress such as rising liabilities or shrinking cash reserves.

  • Operational Efficiency: Given the moderate employee base, focus on productivity and cost control to enhance margins and free up cash.

  • Governance and Risk Management: Maintain robust corporate governance, especially since control is concentrated. This includes clear succession planning and risk mitigation strategies.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.